The MD Magazine Opioid-induced Constipation condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.
The field of gastroenterology is as wide as the the amount of the body that it covers. Because of this there are certain challenges doctors face whether they treat the entire gastrointestinal system or just specific parts.
With a continually growing opioid addiction new guidelines have been adopted looking to help fight this problem across the population. Some concerns have been raised about whether this will cause doctors to shy away from prescribing the medications for patients who can benefit most from them.
Temple University Researchers suggest that a guideline created by Temple University Hospital and Temple University Hospital-Episcopal Campus for prescribing opioids in order to maximize safety and avoid misuse appears to significantly decrease the rate of opioid prescribing for minor and chronic non-cancer pain complaints in an acute care setting.
The number of opioid-related deaths nearly quadrupled from 1999 to 2011 in the US; and while that number continues to increase, one state has made positive strides with the implementation of two initiatives.
Researchers who looked at the potential association between post-diagnosis opioid use and breast cancer recurrence found no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.
A recent study looked at the safety and efficacy of prolonged-release forms of two common opioids-oxycodone and naloxone-in treating chronic pain and opioid-induced constipation, which affects in as many as 40% of opioid-treated patients.
For patients unable to have regular bowel movements the search for effective treatment can be uncomfortable with limited options. A potential new treatment is being tested where a vibrating capsule could help these patients with regular bodily functions.
With 259 million painkiller prescriptions written in 2012 alone, according to the Centers for Disease Control and Prevention (CDC), one of the most common side effects experienced by patients being treated for chronic pain is opioid-induced constipation (OIC).